German packaging firm Gerresheimer has reported healthy first half
financial results, boosted by a series of strategic acquisitions
and favourable market conditions, with the firm's recent initial
public offering promising to...
Just as the biopharma industry was recovering from its hangover
after negative clinical events in the gene therapy field, the death
of a patient during a gene therapy trial last week puts a cloud in
the sky for this promising area...
Sanofi-Aventis' disposable insulin pen SoloStar has been launched
across the US for use with the company's 24-hour basal insulin
Lantus (insulin glargine), despite patent infringement claims
emanating from fellow insulin...
German-based MorphoSys has a positive outlook for its antibody
producing industry, despite the research antibody segment posting
revenue 10 per cent below expectations in the six-month financial
report released today.
Indian biotech heavyweight Biocon has today announced that its
joint venture with Abu Dhabi-based Neopharma has spawned new
company NeoBiocon, operating out of one of Dubai's newest